Polymethyl Methacrylate for Elbow Arthroplasty: Is There Another Way?

Area of Science:

• Orthopedic surgery
• Biomaterials science
• Regulatory affairs

Background:

• Polymethyl methacrylate (PMMA) is the only FDA-approved fixation for total elbow arthroplasty.
• High rates of aseptic loosening associated with PMMA lead to difficult revisions.
• Bone-cement implantation syndrome is a potential complication.

Purpose of the Study:

• To explore the historical background of PMMA in arthroplasty.
• To examine complications associated with PMMA use.
• To review arthroplasty trends and FDA approval challenges.

Main Methods:

• Policy paper review.
• Historical analysis of PMMA.
• Literature review of arthroplasty trends and FDA processes.

Main Results:

• PMMA's long-standing use in arthroplasty.
• Significant rates of aseptic loosening and revision surgery.
• Challenges in the FDA approval pathway for orthopedic implants.

Conclusions:

• The limitations of PMMA necessitate further research into alternative fixation methods.
• Addressing PMMA complications is crucial for improving patient outcomes.
• Streamlining the FDA approval process could facilitate innovation in arthroplasty.